Kalamazoo, Michigan - July 18, 2014 - Stryker Corporation (SYK) announced that it will host an Analyst Meeting on Wednesday, September 17, 2014, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.
Kevin Lobo, President and Chief Executive Officer, will host the meeting with presentations by leaders of the Company`s key business units.
A simultaneous webcast of the meeting will be available on Stryker`s website at www.stryker.com via the Investor page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial (866) 436-9172 (domestic) or (630) 691-2760 (international) and be prepared to provide confirmation number 37534749 to the operator.
A recording of the meeting will be available from 6:30 p.m. Eastern Time, on September 17, 2014, until 11:59 p.m. Eastern Time, on December 17, 2014. To hear this recording, dial (888) 843-7419 (domestic) or (630) 652-3042 (international) and enter passcode 37534749 #.
This presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; the ultimate total cost with respect to the Rejuvenate and ABG II matter; the impact of investigative and legal proceedings and compliance risks; resolution of tax audits; the impact of the federal legislation to reform the United States healthcare system; changes in financial markets; changes in the competitive environment; our ability to integrate acquisitions; and our ability to realize anticipated cost savings as a result of workforce reductions and other restructuring activities. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker is one of the world`s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please contact us for more information at www.stryker.com.
For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or firstname.lastname@example.org
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Stryker Corporation via GlobeNewswire